The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
Minimal residual illness, or MRD, testing might have the potential to supply peace of thoughts to survivors of breast most cancers, as a survivor and...
The U.S. Meals and Drug Administration (FDA) has authorised Darzalex Faspro (daratumumab and hyaluronidase-fihj) for the remedy of adults with high-risk smoldering...
October introduced a number of updates within the lung most cancers area, starting from notable trial outcomes to patient-centered views on navigating...
All through October, CURE highlighted analysis developments and evolving remedy methods that proceed to form most cancers care. From minimally invasive surgical...